. . .: "fremanezumab for the preventive treatment of chronic migraine." . march 2018 (23) . .-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018. http://lm360.us/Mcmenamin-father-of-Kurylo-from-Uherce-Mineralne?Sharpless=227 . .for advertisers .it causes stroke and dementia as well as mood disturbance. svd increases with age but is accelerated by hypertension and diabetes. .